Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, +1432

The Lancet

Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyCardiovascular Outcomes +7

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, +1434

The Lancet

Metabolic SyndromeDiabetes ManagementUrologyChronic Kidney DiseaseDiabetes +8

Mutational Spectrum of the Steroid 21-Hydroxylase Gene in Austria: Identification of a Novel Missense Mutation

Sabina Baumgartner‐Parzer, E Schulze, W Waldhäusl, +7

The Journal of Clinical Endocrinology & Metabolism

Family MembersUnrelated Austrian PatientsGeneticsMolecular BiologyPathology +18

Divergence between genotype and phenotype in relatives of patients with the intron 2 mutation of steroid-21-hydroxylase

E Schulze, Gunter Scharer, A. Rogatzki, +6

Endocrine Research

Metabolism of glucocorticoids and mineralocorticoids in patients with adrenal incidentalomas

Christiane Maser‐Gluth, Martín Reincke, Bruno Allolio, +1

European Journal of Clinical Investigation

Mutational Analysis of the PHEX Gene: Novel Point Mutations and Detection of Large Deletions by MLPA in Patients with X-Linked Hypophosphatemic Rickets

Susanne Clausmeyer, V. Hesse, P. Clemens, +6

Calcified Tissue International

Mutational AnalysisGenetic DisorderMedicineGeneticsPhex Gene +8

New Mutations in the RET Protooncogene-L881V – Associated with Medullary Thyroid Carcinoma and -R770Q – in a Patient with Mixed Medullar/Follicular Thyroid Tumour

Karin Frank‐Raue, J. Döhring, G. Scheumann, +6

Experimental and Clinical Endocrinology & Diabetes

Allele-dropout using pcr-based diagnosis for the splicing mutation in intron-2 of the CYP21B-gene: successful amplification with a TAQ/PWO-polymerase mixture

E Schulze, Markus Bettendorf, Christiane Maser‐Gluth, +2

Endocrine Research

GeneticsRna SplicingGenetic EpidemiologyMolecular BiologyPathology +21

Primary Hyperparathyroidism as the Leading Symptom in a Patient with a Y791F RET Mutation

H Vierhapper, Susanne Rondot, E Schulze, +6

Thyroid